ELA026

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)NCT05416307ETRAPhase 2, Phase 3Recruiting2028-03Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.